health - "develop"

Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients. Unfortunately, some of the most effective therapies also have toxic side effects that can pose serious health risks and reduce quality of life. In the October issue of Mayo Clinic Proceedings, two articles authored by Mayo researchers address the issue of how to balance the risks and benefits associated with MM treatments.

Air pollution may increase risk of developing the life-threatening condition appendicitis, research suggests.

Avian flu isn't in the news as much lately, but it remains a focus of the Centers for Disease Control and Prevention. David D. Ho, scientific director of the Aaron Diamond AIDS Research Center, and Rockefeller's Irene Diamond Professor, along with his colleagues at Taiwan's Academia Sinica, has developed a DNA based vaccine that shows promise for halting most variations of H5N1 flu. The scientists, rather than using dead virus, have built a vaccine that stimulates immunity against Avian flu in mice.read more

NEW YORK (Reuters) - A low pressure system in the oil-rich Bay of Campeche in the southwest Gulf of Mexico has a 20 percent to 50 percent chance of developing over the next 48 hours, the U.S. National...

Breastfeeding continues to be one of the primary routes of HIV transmission in the developing world. The World health Organization (WHO) estimates that 150,000 babies around the world are infected...

Is your relationship like most other couples or has it developed into a truly abusive one? Take this quiz to determine if your relationship is considered abusive.

Each year, more than two million people die from alcohol-related causes which is why World health Organization (WHO) was asked by its Member States in May at the World Health Assembly to develop a global strategy to combat the harmful use of alcohol. All parties with an interest in reducing the harmful use of alcohol are now invited to share their views in a public hearing being organized by the World Health Organization (WHO).

Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the completion of enrollment in two, phase 2 clinical studies of PRO 140, an investigational drug that is being developed for treatment of human immunodeficiency virus (HIV) infection. The phase 2 studies are separately evaluating intravenous and subcutaneous forms of PRO 140.

StemCells, Inc. (Nasdaq:STEM) announced that it has been awarded a $305,000 grant from the National Institute of Diabetes and Digestive and Kidney Diseases to research and develop a potential cell-based therapeutic for liver disease arising from infection by the hepatitis C virus (HCV). Hepatitis C is a global health challenge, with approximately 170 million people affected worldwide and an estimated three million new infections each year.

(Juvenile Diabetes Research Foundation International) A research study funded by JDRF suggests that a common intestinal bacteria may provide some protection from developing type 1 diabetes. The findings provide an important step towards understanding how and why type 1 diabetes develops in people, and may lead to potential cures.